CA
NZ
UK
AU
IND
US
On the second quarter call, management reported record applicator sales but a sharp drop in system sales, citing used-deviceMarket Saturationand industry disruption from Medicare reimbursement cuts. The company release pointed to Medicare reimbursement developments and a 2027 CMS proposed rule for code 97610. Applicators …
Operating income was USD 1.6 million versus an operating loss of USD 0.8 million, andNet Incomefrom continuing operations was USD 1.4 million compared with a loss of USD 0.1 million. Gross margin fell to 26.2% of sales from 29.7% even as gross profit increased, …
The company is a Cayman IslandsHolding Companywhose operations run through a ChineseSubsidiaryproviding supply chain management services for the apparel industry, covering yarn products, textiles and finished garments. Buying oncology patents is therefore a sharp change of direction, and patents alone do not generateRevenueuntil they …
Key HighlightsACRES Commercial Realty (NYSE:ACR) reported a third-quarterGAAPnet loss allocable to common shares of USD 56.3 million, or USD 5.16 per diluted share, against income of USD 9.8 million, or USD 1.34, a year earlier.Earnings available for distribution, a non-GAAP measure, were a loss …
Published coverage of the company filing says Nasdaq found the stock closed below USD 1.00 for 30 consecutiveBusinessdays from September 15, 2026 through October 26, 2026. Because reverse splits within two years totalled 1-for-2,000 (1-for-10 on July 8, 2025, 1-for-20 on May 8, 2026 …
Key HighlightsEnact Holdings (NASDAQ:ACT) reported third-quarterNet Incomeof USD 159 million, or USD 1.15 per diluted share, while adjustedOperating Incomewas USD 164 million, or USD 1.19 per share.The company raised its 2026Capitalreturn expectation to approximately USD 600 million and declared a quarterlyDividendof USD 0.24 a …
Chairman and Chief Executive Byron Allen called it a transitional quarter. Following the Allen Family Digital majority stake completed in May 2026, a July restructuring cut about 35% of workforce and dedicated contractors, targeting USD 30 million of annualized savings. Management is focusing on …
Cost of product revenue fell to USD 41.2 million from USD 58.6 million, mainly because normal source plasma sales, a lower-margin line, stopped and BIVIGAMVolumedeclined. Management also credits theYieldenhancement process approved by the FDA in April 2025, which it says raises ASCENIV and BIVIGAM …
A reverse split cuts the share count and lifts the quoted price in proportion, but it does not change the company's total market value. Its usual purpose is to satisfy theNasdaqminimum bid rule, and published coverage indicates compliance was regained on September 17, 2026. …
Key HighlightsAdient (NYSE:ADNT) reported a fiscal fourth-quarterGAAPnet loss attributable to the company of USD 47 million, or USD 0.62 per share, against income of USD 18 million, or USD 0.22, a year earlier.AdjustedDiluted Earnings per Sharewere unchanged at USD 0.52, as adjustedNet Incomeslipped to …
Please wait processing your request...